VERTEX PHARMACEUTICALS INC / MA Insider Trading for February 2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for February 2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 26 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.35 | 5,130 | 181,346 | 97,480 | |
| Feb 26 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 86.50 | 1,830 | 158,295 | 269,295 | 271.1 K to 269.3 K (-0.67 %) |
| Feb 26 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 85.20 | 1,700 | 144,840 | 271,125 | 272.8 K to 271.1 K (-0.62 %) |
| Feb 26 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 84.03 | 1,400 | 117,642 | 272,825 | 274.2 K to 272.8 K (-0.51 %) |
| Feb 26 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 82.90 | 200 | 16,580 | 274,225 | 274.4 K to 274.2 K (-0.07 %) |
| Feb 26 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.35 | 5,130 | 181,346 | 274,425 | 269.3 K to 274.4 K (+1.90 %) |
| Feb 19 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.35 | 5,130 | 181,346 | 102,610 | |
| Feb 19 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 87.53 | 1,830 | 160,180 | 265,284 | 267.1 K to 265.3 K (-0.69 %) |
| Feb 19 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 86.74 | 3,000 | 260,220 | 267,114 | 270.1 K to 267.1 K (-1.11 %) |
| Feb 19 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 85.16 | 300 | 25,548 | 270,114 | 270.4 K to 270.1 K (-0.11 %) |
| Feb 19 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.35 | 5,130 | 181,346 | 270,414 | 265.3 K to 270.4 K (+1.93 %) |
| Feb 12 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.35 | 5,130 | 181,346 | 107,740 | |
| Feb 12 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 83.34 | 1,400 | 116,676 | 265,284 | 266.7 K to 265.3 K (-0.52 %) |
| Feb 12 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 82.64 | 2,400 | 198,336 | 266,684 | 269.1 K to 266.7 K (-0.89 %) |
| Feb 12 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 81.65 | 1,330 | 108,595 | 269,084 | 270.4 K to 269.1 K (-0.49 %) |
| Feb 12 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.35 | 5,130 | 181,346 | 270,414 | 265.3 K to 270.4 K (+1.93 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Option Exercise | M | 35.35 | 5,130 | 181,346 | 112,870 | |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 93.61 | 530 | 49,613 | 265,284 | 265.8 K to 265.3 K (-0.20 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 92.94 | 800 | 74,352 | 265,814 | 266.6 K to 265.8 K (-0.30 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 91.58 | 700 | 64,106 | 266,614 | 267.3 K to 266.6 K (-0.26 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 90.63 | 1,300 | 117,819 | 267,314 | 268.6 K to 267.3 K (-0.48 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 89.60 | 1,100 | 98,560 | 268,614 | 269.7 K to 268.6 K (-0.41 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 88.11 | 500 | 44,055 | 269,714 | 270.2 K to 269.7 K (-0.19 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Sell | S | 86.66 | 200 | 17,332 | 270,214 | 270.4 K to 270.2 K (-0.07 %) |
| Feb 05 2016 | VRTX | VERTEX PHARMACEUTI ... | BOGER JOSHUA S | Director | Buy | M | 35.35 | 5,130 | 181,346 | 270,414 | 265.3 K to 270.4 K (+1.93 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Option Exercise | A | 91.05 | 34,482 | 3,139,586 | 34,482 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 92.73 | 1,652 | 153,190 | 112,999 | 114.7 K to 113 K (-1.44 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 91.68 | 1,200 | 110,016 | 114,651 | 115.9 K to 114.7 K (-1.04 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 90.97 | 4,232 | 384,985 | 115,851 | 120.1 K to 115.9 K (-3.52 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Sell | S | 89.90 | 5,000 | 449,500 | 120,083 | 125.1 K to 120.1 K (-4.00 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | SMITH IAN F | EVP & CFO | Grant | A | 0.01 | 17,299 | 173 | 125,083 | 107.8 K to 125.1 K (+16.05 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | A | 91.05 | 20,625 | 1,877,906 | 20,625 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 93.06 | 200 | 18,612 | 16,750 | 17 K to 16.8 K (-1.18 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 92.43 | 662 | 61,189 | 16,950 | 17.6 K to 17 K (-3.76 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 91.07 | 1,900 | 173,033 | 17,612 | 19.5 K to 17.6 K (-9.74 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 89.96 | 2,300 | 206,908 | 19,512 | 21.8 K to 19.5 K (-10.54 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Grant | A | 0.01 | 6,875 | 69 | 21,812 | 14.9 K to 21.8 K (+46.03 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Option Exercise | A | 91.05 | 34,482 | 3,139,586 | 34,482 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 92.79 | 1,266 | 117,472 | 86,096 | 87.4 K to 86.1 K (-1.45 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 91.82 | 900 | 82,638 | 87,362 | 88.3 K to 87.4 K (-1.02 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 91.01 | 3,700 | 336,737 | 88,262 | 92 K to 88.3 K (-4.02 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Sell | S | 89.91 | 4,300 | 386,613 | 91,962 | 96.3 K to 92 K (-4.47 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, Policy, Access ... | Grant | A | 0.01 | 17,299 | 173 | 96,262 | 79 K to 96.3 K (+21.91 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Option Exercise | A | 91.05 | 107,276 | 9,767,480 | 107,276 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 92.87 | 1,034 | 96,028 | 261,885 | 262.9 K to 261.9 K (-0.39 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 91.96 | 900 | 82,764 | 262,919 | 263.8 K to 262.9 K (-0.34 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 91.01 | 3,700 | 336,737 | 263,819 | 267.5 K to 263.8 K (-1.38 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Sell | S | 89.91 | 4,200 | 377,622 | 267,519 | 271.7 K to 267.5 K (-1.55 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | LEIDEN JEFFREY M | CEO & President | Grant | A | 0.01 | 53,817 | 538 | 271,719 | 217.9 K to 271.7 K (+24.70 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | A | 91.05 | 28,735 | 2,616,322 | 28,735 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 91.80 | 1,275 | 117,045 | 112,603 | 113.9 K to 112.6 K (-1.12 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 90.89 | 1,100 | 99,979 | 113,878 | 115 K to 113.9 K (-0.96 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Grant | A | 0.01 | 14,416 | 144 | 114,978 | 100.6 K to 115 K (+14.34 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | A | 91.05 | 34,482 | 3,139,586 | 34,482 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 92.80 | 645 | 59,856 | 115,721 | 116.4 K to 115.7 K (-0.55 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 91.89 | 700 | 64,323 | 116,366 | 117.1 K to 116.4 K (-0.60 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 90.98 | 2,100 | 191,058 | 117,066 | 119.2 K to 117.1 K (-1.76 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 89.92 | 2,597 | 233,522 | 119,166 | 121.8 K to 119.2 K (-2.13 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Grant | A | 0.01 | 17,299 | 173 | 121,763 | 104.5 K to 121.8 K (+16.56 %) |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Option Exercise | A | 91.05 | 28,735 | 2,616,322 | 28,735 | |
| Feb 04 2016 | VRTX | VERTEX PHARMACEUTI ... | ALTSHULER DAVID | EVP, Global Researc ... | Grant | A | 0.01 | 14,416 | 144 | 89,416 | 75 K to 89.4 K (+19.22 %) |